- Senior Managing Director, Center for Technology Licensing at Weill Cornell Medicine
Dr. Lisa Placanica is senior managing director, Center for Technology Licensing at Weill Cornell Medicine. In this role, she is responsible for overseeing activities in technology management, marketing, licensing and outreach to support Cornell’s goals in commercializing technologies, promoting startups and building alliances. As part of Weill Cornell Medicine’s research leadership, she provides strategic guidance and advice to senior leadership on matters relating to intellectual property, innovation and entrepreneurship and the formation, launch and operation of Weill Cornell Medicine Enterprise Innovation.
Prior to joining Weill Cornell Medicine in 2020, Dr. Placanica held the position of managing director, Business Development and Licensing at Mount Sinai Innovation Partners. In this role, she was responsible for managing a team of business development professionals focused on identifying, advancing and partnering therapeutic technologies developed at the Mount Sinai Health System and acted as deal team lead for closing complex intellectual property transactions. Dr. Placanica was also a licensing manager in the Office of Technology Development at Memorial Sloan Kettering Cancer Center where she focused on development and commercialization of cell and gene therapy related inventions and previously was a key member of the Cell Biology research group at Athersys, Inc in Cleveland, Ohio.
Dr. Placanica received her Ph.D. in Pharmacology from Weill Cornell Graduate School of Medical Sciences where she studied the biochemical composition of gamma secretase and its role in Alzheimer’s Disease in the laboratory of Dr. Yueming Li at Memorial Sloan Kettering Cancer Center. She holds a B.A. in Biology from Cornell University where she graduated Magna Cum Laude with Distinction.
In 2013, Dr. Placanica became a Certified Licensing Professional.